Speaker illustration

Doctor Teona Shvangiradze

Endocrinology Research Center, Moscow (Russian Federation)

Transforming growth factor beta and fibroblast growth factor 21 in cardiovascular prognosis in patients with obesity and type 2 diabetes mellitus

Event: ESC Congress 2017

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session: Diabetes

Thumbnail

Cardiovascular-related microRNAs in patients with obesity and type 2 diabetes mellitus

Event: ESC Congress 2017

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session: Diabetes

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb